<DOC>
	<DOCNO>NCT00084526</DOCNO>
	<brief_summary>RATIONALE : New image procedure CT-on-rails™ may improve ability pinpoint location tumor decrease radiation therapy damage healthy tissue . PURPOSE : This phase I/II trial study well compute tomography ( CT ) scan use CT-on-rails™ work pinpoint location tumor patient prostate cancer .</brief_summary>
	<brief_title>Computed Tomography ( CT ) Scans Using CT-On-Rails™ Pinpoint Location Tumor Treating Patients With Prostate Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Validate software CT-on-rails™ comparing prostate target localization via daily ultrasound v compute tomography ( CT ) patient undergo radiotherapy prostate cancer . Secondary - Determine potential benefit use fiducials prostate patient undergoing daily CT scan and/or ultrasounds localization . - Determine intra- inter-radiation treatment setup target position uncertainty , term isocenter coordinate space , use ultrasound CT scan compare coordinate isocenter determine simulation , patient . OUTLINE : This pilot study . - Phase I : Patients undergo compute tomography ( CT ) use CT-on-rails™ twice weekly . Patients undergo BAT™ ultrasound daily prostate localization . Patients undergo concurrent daily radiotherapy study image . After radiotherapy treatment complete , patient continue undergo scan use CT-on-rails™ twice weekly . - Phase II : Patients undergo local anesthesia surgical insertion gold fiducial marker prostate . After 1 week , patient undergo daily CT scan use CT-on-rails™ bi-weekly BAT™ ultrasound . Patients undergo daily radiotherapy study image . After radiotherapy treatment complete , patient continue undergo scan use CT-on-rails™ twice weekly . PROJECTED ACCRUAL : A total 40 patient ( 20 per study phase ) accrue study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis definitive prostate cancer Radiotherapy plan treatment PATIENT CHARACTERISTICS : Age Any age Performance status Not specify Life expectancy Not specify Hematopoietic Not specify Hepatic Not specify Renal Not specify PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy Not specify Endocrine therapy Not specify Radiotherapy See Disease Characteristics Surgery Not specify</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>recurrent prostate cancer</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage II prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>